Pathwork Diagnostics Closes $30M Series C Round, Plans Investments in Sales Team, New Tests | GenomeWeb

This story was originally published on Oct. 8.

By Justin Petrone

Pathwork Diagnostics will use the proceeds from its latest round of financing to expand its sales and marketing activities and grow its menu of microarray-based tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.